
2019 | 2018 | |||||||
(Amounts in millions except per share data) | ||||||||
Earnings per share (as reported) | $ | 0.72 | $ | 0.94 | ||||
Adjusted earnings per share1 | $ | 0.77 | $ | 0.92 | ||||
Segment operating profit | $ | 758 | $ | 881 | ||||
Adjusted segment operating profit1 | $ | 764 | $ | 861 | ||||
Ag Services and Oilseeds | 417 | 478 | ||||||
Carbohydrate Solutions | 182 | 288 | ||||||
Nutrition | 118 | 67 | ||||||
Other | 47 | 28 | ||||||
• | Ag Services results were in line with the prior-year quarter. In South America, results were up on improved origination margins in Brazil and increased export volumes from Argentina. In North America, improved merchandising results from favorable ownership positions helped offset a continued challenging volume and margin environment for U.S. exports. |
• | In Crushing, results were lower year over year. Crush margins globally were substantially below the record high levels seen in 2018, though still solid in North America and EMEA. In South America, margins were pressured by continued strong exports of soybeans to China. Global crush margins benefited from positive net timing effects of approximately $50 million during the third quarter. |
• | Refined Products and Other results were significantly higher than the third quarter of 2018, largely driven by significant improvements in Golden Peanut and Tree Nuts. |
• | Wilmar results were lower year over year. |
• | Starches and Sweeteners results were down versus the third quarter of 2018. Results in North America were affected by higher net corn costs partly offset by lower manufacturing costs, which included improvements at the Decatur corn complex. EMEA results were impacted by lower selling prices and continued pressure from Turkish sweetener quotas. In wheat milling, an increase in sales volumes was more than offset by lower margins due to limited opportunities in wheat procurement. |
• | Bioproducts results were significantly lower, driven by a continued unfavorable margin environment in the ethanol industry. |
• | WFSI results were significantly higher than the prior-year quarter, with growth across the portfolio. Higher sales and margins globally led to record quarterly results for WILD. In Specialty Ingredients, the protein business continued to expand amid the growing consumer market for alternative proteins. Continued contributions from growth investments in bioactives and fibers benefited the Health & Wellness business. |
• | Animal Nutrition results were up year over year, driven largely by contributions from Neovia. Improvements in vitamin additives also helped contribute to positive results. Lysine production improved, though pricing was negatively impacted by lower global demand. |
Media Relations | Investor Relations |
Jackie Anderson | Victoria de la Huerga |
312-634-8484 | 312-634-8457 |
Quarter ended | Nine months ended | ||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||
(In millions) | 2019 | 2018 | Change | 2019 | 2018 | Change | |||||||||||||
Segment Operating Profit | $ | 758 | $ | 881 | $ | (123 | ) | $ | 2,014 | $ | 2,487 | $ | (473 | ) | |||||
Specified items: | |||||||||||||||||||
(Gains) losses on sales of assets and businesses | — | (21 | ) | 21 | (12 | ) | (21 | ) | 9 | ||||||||||
Impairment, restructuring, and settlement charges | 6 | 1 | 5 | 52 | 36 | 16 | |||||||||||||
Adjusted Segment Operating Profit | $ | 764 | $ | 861 | $ | (97 | ) | $ | 2,054 | $ | 2,502 | $ | (448 | ) | |||||
Ag Services and Oilseeds | $ | 417 | $ | 478 | $ | (61 | ) | $ | 1,196 | $ | 1,405 | $ | (209 | ) | |||||
Ag Services | 161 | 157 | 4 | 326 | 473 | (147 | ) | ||||||||||||
Crushing | 138 | 197 | (59 | ) | 493 | 393 | 100 | ||||||||||||
Refined Products and Other | 80 | 44 | 36 | 223 | 298 | (75 | ) | ||||||||||||
Wilmar | 38 | 80 | (42 | ) | 154 | 241 | (87 | ) | |||||||||||
Carbohydrate Solutions | $ | 182 | $ | 288 | $ | (106 | ) | $ | 470 | $ | 748 | $ | (278 | ) | |||||
Starches and Sweeteners | 207 | 245 | (38 | ) | 595 | 699 | (104 | ) | |||||||||||
Bioproducts | (25 | ) | 43 | (68 | ) | (125 | ) | 49 | (174 | ) | |||||||||
Nutrition | $ | 118 | $ | 67 | $ | 51 | $ | 316 | $ | 277 | $ | 39 | |||||||
WFSI | 102 | 80 | 22 | 293 | 259 | 34 | |||||||||||||
Animal Nutrition | 16 | (13 | ) | 29 | 23 | 18 | 5 | ||||||||||||
Other | $ | 47 | $ | 28 | $ | 19 | $ | 72 | $ | 72 | $ | — | |||||||
Segment Operating Profit | $ | 758 | $ | 881 | $ | (123 | ) | $ | 2,014 | $ | 2,487 | $ | (473 | ) | |||||
Corporate Results | $ | (255 | ) | $ | (249 | ) | $ | (6 | ) | $ | (922 | ) | $ | (739 | ) | $ | (183 | ) | |
Interest expense - net | (85 | ) | (80 | ) | (5 | ) | (276 | ) | (236 | ) | (40 | ) | |||||||
Unallocated corporate costs | (139 | ) | (161 | ) | 22 | (454 | ) | (487 | ) | 33 | |||||||||
Other charges | — | (4 | ) | 4 | (18 | ) | (28 | ) | 10 | ||||||||||
Specified items: | |||||||||||||||||||
LIFO credit (charge) | 16 | (7 | ) | 23 | (10 | ) | 14 | (24 | ) | ||||||||||
Expenses related to acquisitions | — | 4 | (4 | ) | (14 | ) | 4 | (18 | ) | ||||||||||
Restructuring charges | (47 | ) | (1 | ) | (46 | ) | (150 | ) | (6 | ) | (144 | ) | |||||||
Earnings Before Income Taxes | $ | 503 | $ | 632 | $ | (129 | ) | $ | 1,092 | $ | 1,748 | $ | (656 | ) | |||||
Quarter ended | Nine months ended | ||||||||||||||
September 30 | September 30 | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
(in millions, except per share amounts) | |||||||||||||||
Revenues | $ | 16,726 | $ | 15,800 | $ | 48,327 | $ | 48,394 | |||||||
Cost of products sold (1) | 15,648 | 14,742 | 45,349 | 45,266 | |||||||||||
Gross profit | 1,078 | 1,058 | 2,978 | 3,128 | |||||||||||
Selling, general, and administrative expenses (2) | 578 | 534 | 1,839 | 1,607 | |||||||||||
Asset impairment, exit, and restructuring costs (3) | 53 | 1 | 200 | 41 | |||||||||||
Equity in (earnings) losses of unconsolidated affiliates | (88 | ) | (131 | ) | (279 | ) | (378 | ) | |||||||
Interest income | (47 | ) | (40 | ) | (142 | ) | (115 | ) | |||||||
Interest expense | 97 | 87 | 307 | 267 | |||||||||||
Other (income) expense - net (4,5) | (18 | ) | (25 | ) | (39 | ) | (42 | ) | |||||||
Earnings before income taxes | 503 | 632 | 1,092 | 1,748 | |||||||||||
Income tax expense (6) | 95 | 96 | 212 | 250 | |||||||||||
Net earnings including noncontrolling interests | 408 | 536 | 880 | 1,498 | |||||||||||
Less: Net earnings (losses) attributable to noncontrolling interests | 1 | — | 5 | 3 | |||||||||||
Net earnings attributable to ADM | $ | 407 | $ | 536 | $ | 875 | $ | 1,495 | |||||||
Diluted earnings per common share | $ | 0.72 | $ | 0.94 | $ | 1.55 | $ | 2.64 | |||||||
Average diluted shares outstanding | 563 | 568 | 565 | 567 | |||||||||||
September 30, 2019 | September 30, 2018 | |||||||
(in millions) | ||||||||
Net Investment In | ||||||||
Cash and cash equivalents (a) | $ | 932 | $ | 915 | ||||
Short-term marketable securities (a) | 26 | — | ||||||
Operating working capital (b) | 7,457 | 8,024 | ||||||
Property, plant, and equipment | 10,101 | 9,885 | ||||||
Investments in and advances to affiliates | 5,399 | 5,293 | ||||||
Long-term marketable securities | 10 | 26 | ||||||
Goodwill and other intangibles | 5,401 | 4,065 | ||||||
Other non-current assets | 1,715 | 930 | ||||||
$ | 31,041 | $ | 29,138 | |||||
Financed By | ||||||||
Short-term debt (a) | $ | 1,242 | $ | 532 | ||||
Long-term debt, including current maturities (a) | 7,646 | 7,320 | ||||||
Deferred liabilities | 3,205 | 2,240 | ||||||
Temporary equity | 53 | 46 | ||||||
Shareholders’ equity | 18,895 | 19,000 | ||||||
$ | 31,041 | $ | 29,138 | |||||
(a) | Net debt is calculated as short-term debt plus long-term debt, including current maturities less cash and cash equivalents and short-term marketable securities. |
(b) | Current assets (excluding cash and cash equivalents and short-term marketable securities) less current liabilities (excluding short-term debt and current maturities of long-term debt). |
Nine months ended | ||||||||
September 30 | ||||||||
2019 | 2018 | |||||||
(in millions) | ||||||||
Operating Activities | ||||||||
Net earnings | $ | 880 | $ | 1,498 | ||||
Depreciation and amortization | 742 | 706 | ||||||
Asset impairment charges | 50 | 33 | ||||||
Gains on sales of assets | (37 | ) | (45 | ) | ||||
Other - net | 65 | (286 | ) | |||||
Change in deferred consideration in securitized receivables(a) | (5,714 | ) | (5,413 | ) | ||||
Other changes in operating assets and liabilities | 375 | (173 | ) | |||||
Total Operating Activities | (3,639 | ) | (3,680 | ) | ||||
Investing Activities | ||||||||
Purchases of property, plant and equipment | (566 | ) | (555 | ) | ||||
Net assets of businesses acquired | (1,946 | ) | (324 | ) | ||||
Proceeds from sale of business/assets | 43 | 177 | ||||||
Investments in retained interest in securitized receivables(a) | (3,813 | ) | (3,391 | ) | ||||
Proceeds from retained interest in securitized receivables(a) | 9,527 | 8,804 | ||||||
Marketable securities - net | 41 | — | ||||||
Investments in and advances to affiliates | (12 | ) | (127 | ) | ||||
Other investing activities | (23 | ) | (9 | ) | ||||
Total Investing Activities | 3,251 | 4,575 | ||||||
Financing Activities | ||||||||
Long-term debt borrowings | 3 | 762 | ||||||
Long-term debt payments | (615 | ) | (13 | ) | ||||
Net borrowings (payments) under lines of credit | 960 | (317 | ) | |||||
Share repurchases | (150 | ) | — | |||||
Cash dividends | (592 | ) | (568 | ) | ||||
Other | (36 | ) | 32 | |||||
Total Financing Activities | (430 | ) | (104 | ) | ||||
Increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents | (818 | ) | 791 | |||||
Cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period | 3,843 | 1,858 | ||||||
Cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period | $ | 3,025 | $ | 2,649 | ||||
Quarter ended | Nine months ended | |||||||||||||||
September 30 | September 30 | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
(in ‘000s metric tons) | ||||||||||||||||
Processed volumes (by commodity) | ||||||||||||||||
Oilseeds | 9,062 | 9,181 | 27,002 | 27,303 | ||||||||||||
Corn | 5,619 | 5,599 | 16,297 | 16,708 | ||||||||||||
Total processed volumes | 14,681 | 14,780 | 43,299 | 44,011 | ||||||||||||
Quarter ended | Nine months ended | |||||||||||||||
September 30 | September 30 | |||||||||||||||
2019 | 2018 | 2019 | 2018 | |||||||||||||
(in millions) | ||||||||||||||||
Revenues | ||||||||||||||||
Ag Services and Oilseeds | $ | 12,616 | $ | 12,260 | $ | 36,382 | $ | 37,431 | ||||||||
Carbohydrate Solutions | 2,565 | 2,534 | 7,409 | 7,782 | ||||||||||||
Nutrition | 1,457 | 922 | 4,263 | 2,890 | ||||||||||||
Other | 88 | 84 | 273 | 291 | ||||||||||||
Total revenues | $ | 16,726 | $ | 15,800 | $ | 48,327 | $ | 48,394 | ||||||||
Quarter ended September 30 | Nine months ended September 30 | ||||||||||||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||||||||||||
In millions | Per share | In millions | Per share | In millions | Per share | In millions | Per share | ||||||||||||||||||
Net earnings and fully diluted EPS | $ | 407 | $ | 0.72 | $ | 536 | $ | 0.94 | $ | 875 | $ | 1.55 | $ | 1,495 | $ | 2.64 | |||||||||
Adjustments: | |||||||||||||||||||||||||
LIFO charge (credit) (a) | (12 | ) | (0.02 | ) | 5 | 0.01 | 8 | 0.01 | (11 | ) | (0.02 | ) | |||||||||||||
Losses (gains) on sales of assets and businesses (b) | — | — | (20 | ) | (0.04 | ) | (9 | ) | (0.02 | ) | (20 | ) | (0.04 | ) | |||||||||||
Asset impairment, restructuring, and settlement charges (c) | 41 | 0.08 | 2 | — | 156 | 0.28 | 30 | 0.05 | |||||||||||||||||
Expenses related to acquisitions (d) | — | — | (3 | ) | — | 9 | 0.02 | (3 | ) | — | |||||||||||||||
Tax adjustment (e) | (5 | ) | (0.01 | ) | 3 | 0.01 | (7 | ) | (0.01 | ) | (4 | ) | (0.01 | ) | |||||||||||
Sub-total adjustments | 24 | 0.05 | (13 | ) | (0.02 | ) | 157 | 0.28 | (8 | ) | (0.02 | ) | |||||||||||||
Adjusted net earnings and adjusted EPS | $ | 431 | $ | 0.77 | $ | 523 | $ | 0.92 | $ | 1,032 | $ | 1.83 | $ | 1,487 | $ | 2.62 | |||||||||
(a) | Current quarter and YTD changes in the Company’s LIFO reserves of $16 million and $10 million pretax, respectively ($12 million and $8 million after tax, respectively), tax effected using the Company’s U.S. income tax rate. Prior quarter and YTD changes in the Company’s LIFO reserves of $7 million and $14 million pretax, respectively ($5 million and $11 million after tax, respectively), tax effected using the Company’s U.S. income tax rate. |
(b) | Current YTD gains of $12 million pretax ($9 million after tax), consisted of a gain on the sale of certain assets and a step-up gain on an equity investment, tax effected using the Company’s U.S. income tax rate. Prior quarter and YTD gains of $21 million pretax ($20 million after tax) related to the sale of a business and an equity investment, tax effected using the applicable tax rates. |
(c) | Current quarter charges of $53 million pretax ($41 million after tax) related to the impairment of certain assets, restructuring, and pension settlement, tax effected using the applicable rates. Current YTD charges of $202 million pretax ($156 million after tax) related to the impairment of certain assets, restructuring, and pension settlement, tax effected using the applicable tax rates. Prior quarter charges of $2 million pretax and after tax related to restructuring charges and a settlement charge, tax effected using the applicable tax rates. Prior YTD charges of $42 million pretax ($30 million after tax) related to impairment of certain assets, restructuring charges and a settlement charge, tax effected using the applicable tax rates. |
(d) | Current YTD acquisition expenses of $14 million pretax ($9 million after tax), consisted of expenses related to the Neovia acquisition. Prior quarter and YTD acquisition adjustment of $4 million pretax ($3 million after tax) related to net gains on foreign exchange derivative contracts to economically hedge certain acquisitions. |
(e) | Tax adjustment due to the U.S. tax reform and certain discrete items totaling ($5 million) and ($7 million) in the current quarter and YTD, respectively, and $3 million and ($4 million) in the prior quarter and YTD, respectively. |
Adjusted ROIC Earnings (in millions) | |||||||||||||||||||
Four Quarters | |||||||||||||||||||
Quarter Ended | Ended | ||||||||||||||||||
Dec. 31, 2018 | Mar. 31, 2019 | June 30, 2019 | Sep. 30, 2019 | Sep. 30, 2019 | |||||||||||||||
Net earnings attributable to ADM | $ | 315 | $ | 233 | $ | 235 | $ | 407 | $ | 1,190 | |||||||||
Adjustments: | |||||||||||||||||||
Interest expense | 97 | 101 | 109 | 97 | 404 | ||||||||||||||
LIFO | (4 | ) | 1 | 25 | (16 | ) | 6 | ||||||||||||
Other adjustments (3) | 241 | 30 | 119 | 48 | 438 | ||||||||||||||
Total adjustments | 334 | 132 | 253 | 129 | 848 | ||||||||||||||
Tax on adjustments | (80 | ) | (28 | ) | (65 | ) | (32 | ) | (205 | ) | |||||||||
Net adjustments | 254 | 104 | 188 | 97 | 643 | ||||||||||||||
Total Adjusted ROIC Earnings | $ | 569 | $ | 337 | $ | 423 | $ | 504 | $ | 1,833 | |||||||||
Adjusted Invested Capital (in millions) | |||||||||||||||||||
Quarter Ended | Trailing Four | ||||||||||||||||||
Dec. 31, 2018 | Mar. 31, 2019 | June 30, 2019 | Sep. 30, 2019 | Quarter Average | |||||||||||||||
Equity (1) | $ | 18,981 | $ | 18,895 | $ | 18,955 | $ | 18,873 | $ | 18,926 | |||||||||
+ Interest-bearing liabilities (2) | 8,392 | 9,887 | 9,417 | 8,891 | 9,147 | ||||||||||||||
+ LIFO adjustment (net of tax) | 41 | 42 | 61 | 49 | 48 | ||||||||||||||
Other adjustments (3) | 183 | 27 | 86 | 36 | 83 | ||||||||||||||
Total Adjusted Invested Capital | $ | 27,597 | $ | 28,851 | $ | 28,519 | $ | 27,849 | $ | 28,204 | |||||||||
Adjusted Return on Invested Capital | 6.5 | % | |||||||||||||||||